11 unknown. 11 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Unknown 11 |
| Phase 2 | 3 | Unknown 3 |
Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis ICP-488, Placebo - Psoriasis | Phase 1 | Unknown | Beijing InnoCare Pharma Tech Co., Ltd. | 154 | 2022-07-29 | 2023-04-18 |
| Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis CT303 - Moderate to Severe Plaque Psoriasis | Phase 1 | Unknown | GC Cell Corporation | 24 | 2021-10-25 | 2022-03-18 |
| Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis Umbilical cord mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis | Phase 1 / Phase 2 | Unknown | Guangdong Provincial Hospital of Traditional Chinese Medicine | 5 | 2021-08-31 | 2021-02-09 |
| An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients Secukinumab 300 MG, Secukinumab 150 MG, Methotrexate - Psoriatic Arthritis | Phase 1 | Unknown | Peking Union Medical College Hospital | 60 | 2021-07-15 | 2021-07-20 |
| Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis PSORI-CM01 formula, Gu Ben Hua Yu formula, adipose-derived multipotent mesenchymal stem cells - Traditional Chinese Medicine, Drug Effect | Phase 1 / Phase 2 | Unknown | Guangdong Provincial Hospital of Traditional Chinese Medicine | 16 | 2021-03-17 | 2023-08-24 |
| A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers Hemay005 - Psoriasis | Phase 1 | Unknown | Tianjin Hemay Bio-Tech Co., Ltd | 12 | 2018-10-10 | 2018-07-05 |
| Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects Hemay005, Placebo - Psoriasis | Phase 1 | Unknown | Tianjin Hemay Bio-Tech Co., Ltd | 24 | 2018-07-10 | 2018-10-02 |
| Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis Low-dose UC-MSCs, High-dose UC-MSCs, Methotrexate - Moderate and Severe Plaque Psoriasis | Phase 1 | Unknown | Tianjin Ever Union Biotechnology Co., Ltd. | 57 | 2018-06-01 | 2018-04-20 |
| Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis FURESTEM-CD Inj. - Psoriasis | Phase 1 | Unknown | Kang Stem Biotech Co., Ltd. | 9 | 2018-01-17 | 2018-03-14 |
| BE Study in Patients - Methotrexate Tablets Methotrexate - Amneal, Methotrexate - DAVA - Psoriasis, Rheumatoid Arthritis | Phase 1 | Unknown | Amneal Pharmaceuticals, LLC | 48 | 2016-08-01 | 2016-10-21 |
| A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 IDP-118 Low Strength, IDP-118 High Strength - Plaque Psoriasis | Phase 1 / Phase 2 | Unknown | Dow Pharmaceutical Sciences | 60 | 2012-06-01 | 2013-04-25 |
Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Drug-Related Side Effects and Adverse Reactions (1) · Lymphoma, Follicular (1)
Skin Diseases (11) · Skin Diseases, Papulosquamous (11) · Skin and Connective Tissue Diseases (11) · Arthritis (2) · Immune System Diseases (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Autoimmune Diseases (1) · Bone Diseases (1) · Chemically-Induced Disorders (1) · Connective Tissue Diseases (1) · Hemic and Lymphatic Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1)
Methotrexate (3) · Hemay005 (2) · secukinumab (1)
Guangdong Provincial Hospital of Traditional Chinese Medicine (2) · Tianjin Hemay Bio-Tech Co., Ltd (2) · Amneal Pharmaceuticals, LLC (1) · Beijing InnoCare Pharma Tech Co., Ltd. (1) · Dow Pharmaceutical Sciences (1) · GC Cell Corporation (1) · Kang Stem Biotech Co., Ltd. (1) · Peking Union Medical College Hospital (1) · Tianjin Ever Union Biotechnology Co., Ltd. (1)
China (6) · South Korea (2) · India (1) · United States (1)
Hongyun Wang, Doctor (2) · Chuanjian Lu, PhD (1) · Chunlei Zhang, doctor (1) · Chunting Li, doctor (1) · Jinzhu Guo, doctor (1) · Prayag N Shah, MD (1) · Qianjin Lu (1) · Seongjin Jo (1) · Taeyoon Kim (1) · Todd Plott, MD (1) · Wenhui Wang, doctor (1) · Xin Guan, doctor (1)